Speaker

Santi Vege

Salient points from the CV of Santhi Swaroop Vege, MACG, AGAF, FACP

Clinical experience:

45 years after completion of fellowship in GI (~30 years at Mayo Clinic, Rochester and 14 years at Tata Memorial Center, Bombay)

Professor of Medicine at Mayo Clinic since 2004 (22 years)

Bibliography:

  1. Over 220 peer-reviewed full manuscripts (including JAMA, NEJM, Gastroenterology)

  2. Over 100 letters, abstracts, editorials

  3. Over 15 book chapters, including topics in UpToDate for more than 15 years and Sleisenger Textbook of Gastroenterology

Guidelines:

  1. Acute pancreatitis guidelines 2013 and 2024, senior corresponding author for ACG

  2. Acute pancreatitis guidelines for APA/IAP 2013 and current IAP 2025 executive member (in press)

  3. Acute pancreatitis technical review for guidelines 2018, senior author AGA

  4. Microscopic colitis 2015 AGA

  5. ICI GI toxicity (in press), pancreas involvement for ACG

  6. Surveillance of Metaplastic and Premalignant Conditions of the GI Tract in the Geriatric Population (in press) for AGA

  7. Pancreas cysts 2015, senior author for AGA

  8. Revised Atlanta classification on acute pancreatitis 2012 – one of the small working group of authors

  9. Lead member for the international group (~40) on revision of revised Atlanta for IAP

ACG leadership:

  1. International governor from India for 2 terms (1992–1996); initiated efforts to increase ACG membership from India

  2. Education committee, international committee — more than once and currently active

AGA leadership:

  1. AGA Council member for 5 years

  2. AGA Pancreas section vice chair (2 years) and chair (3 years)

  3. AGA pancreas section councillor (current)

APA leadership:

  1. Clinical practice guideline committee chair for 2 years

  2. Scientific committee member for the combined APA, IAP, JPS meeting December 2024

IAP leadership:

  1. President (2022–2024)

  2. Treasurer (2014–2018)

  3. Inducted a new region, Central Asia, into IAP with a scientific meeting planned in 2025 in Baku, Azerbaijan

  4. Executive committee member, IAP

Mayo Clinic:

  1. Director, pancreas clinic for 8 years prior to 2021

  2. Member, international committee and regional chair for India & South East Asia for many years

  3. Committee member for education, diversity, practice in internal medicine and gastroenterology (past)

Journals:

  1. American Journal of Gastroenterology — current & past editorial board member

  2. Gastroenterology — current & past editorial board member

  3. Pancreatology — past associate editor for a few years

  4. Indian Journal of Gastroenterology — editorial board member

  5. Reviewer for decades for journals including NEJM, Annals of Surgery, Gastroenterology, Am J Gastroenterol

Honors:

  1. AGA distinguished clinical research mentor award, pancreas section (2023)

  2. Master of ACG (>10 years ago)

  3. Honorary member of Czech Gastroenterology Society

  4. Henry Plummer distinguished clinician award, Mayo Clinic (many years ago)

  5. Honorary membership in Brazilian College of Surgeons (10 years ago)

  6. Member, WHO scientific advisory board for colorectal cancer (1986)

  7. James Lipsky Service Award for General Internal Medicine (2005, Mayo Clinic)

  8. Excellence in teaching recognition for Internal Medicine Residents (2002–2004, Mayo Clinic)

  9. Scientific advisor to International Clinical Research Center, Brno, Czech Republic (5 years)

  10. Outstanding Teacher in Physical Diagnosis, Department of Internal Medicine, Mayo Clinic (2001)

Other leadership & academic contributions:

  • Program Director for Advanced Fellowship in Medical Pancreatology for 8 years (only program in the US at that time)

  • Mentored more than 30 individuals now in leadership positions in universities across India, USA, Mexico

  • Scientific committee member for meetings in USA, India, Brazil, Argentina, South Africa, UAE

  • Delivered more than 300 keynote addresses, orations, invited lectures, oral presentations

  • Visiting professor to universities worldwide, including Dartmouth, Duke, Cedar Sinai, Emory, Harvard, Wash U, USC, Amsterdam, Rotterdam, Munich, Verona, Kyoto, Tokyo, Delhi, Bombay, Hyderabad, Chandigarh, Nanjing, Nanchang, Sao Paulo, Alicante, Heidelberg, Budapest, Brno, Olomouc, Prague, among others

Federal (extramural) grants:

  1. R21 NIDDK: Pentoxifylline/placebo in acute pancreatitis (published one of only two drug trials in AP at that time, both with PI)

  2. DOD grant: Pirfenidone in AP RCT with UAB 2022 (ongoing, Mayo PI)

  3. NIDDK U01 consortium CPDPC, site PI Mayo (9 centers, entering last year of second 5-year cycle)

  4. DOD grant: Pirfenidone in RAP RCT with UAB 2023 (site PI for Mayo)

  5. NIDDK: Lacosamide in CP 2022 (Indiana primary site, Mayo PI)

  6. R21 NIDDK: Indomethacin in CP PAIR study (Ohio State & Mayo, PI, completed recruitment)

  7. NIDDK U01 consortium T1DAP, Diabetes in AP 2021 (advisor to California centers)

  8. NIDDK: CBT in CP 2024 (Seattle Children primary, Mayo PI)

Intra-mural grants:

  1. MIDAS, Mayo Clinic for prospective study of AP (2004)

  2. CP-10, Mayo Clinic: Islet cell autotransplantation (2006)